Table 1

Characteristics of included studies

Study and countrySample sizeStudy typeMean ageAge rangeSeverity of Covid-19Method of diagnosis
Ji et al and
China16
2 (0 female)Case series12 years9–15 yearsMild (n=2)RT-PCR
Liu et al and
China18
5 (1 female)Case series5.9 years7 months to 13 yearsAsymptomatic (n=1), mild (n=1), moderate (n=3)RT-PCR
Lu et al and
China20
171 (67 female)Case series6.71 day to 15 yearsAsymptomatic (n=27), mild (n=33), moderate (n=108), severe (n=3)RT-PCR
Qiu et al and
China22
36 (13 female)Case series8.31–16Mild (n=17), moderate (n=19)RT-PCR
Sun et al and
China23
8 (2 female)Case seriesNot stated2 months to 15 yearsSevere (n=8)RT-PCR
Xia et al and
China24
20 (7 female)Case series2.1 years1 day to 14.7 yearsModerate (n=20)Nucleic acid test
Zhang et al and
China25
3 (0 female)Case series7.7 years6–9 yearsMild (n=1), moderate (n=2)RT-PCR
Zheng et al and
China26
25 (11 female)Case series3 years (median)3 months to 14 yearsMild (n=8), moderate (n=15), severe (n=2)RT-PCR
Cui et al and
China15
1 (1 female)Case report55 daysN/AModerate (n=1)RT-PCR
Kam et al and
Singapore17
1 (0 female)Case report6 monthsN/AMild (n=1)RT-PCR
Liu et al and
China19
1 (0 female)Case report10 yearsN/AMild (n=1)RT-PCR
Park et al and
Korea21
1 (1 female)Case report10 yearsN/AModerate (n=1)RT-PCR
Cai et al and
China14
10 (6 female)Case series6 years3–131 monthsMild (n=6), moderate (n=4)RT-PCR
  • RT, reverse transcription.